A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss

American Journal of Reproductive Immunology

Volumn 63, Issue 2, 2010, Pages 126-136

  Yenicesu, Gonca Imir ^a   Cetin, Meral ^a   Ozdemir, Ozturk ^a   Cetin, Ali ^a   Ozen, Filiz ^a   Yenicesu, Cem ^b   Yildiz, Caglar ^a   Kocak, Nadir ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Cayiralan State Hospital   (Turkey)

Author keywords

Couples; Mutation; Recurrent pregnancy loss; Thrombophilic genes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN B; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOGEN; GLYCOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN GPIIIA; PROTHROMBIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; TURKEY (REPUBLIC);

ABORTION, HABITUAL; ADOLESCENT; ADULT; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FACTOR V; FEMALE; FIBRINOGEN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTEGRIN BETA3; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PEPTIDYL-DIPEPTIDASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; PROTHROMBIN; THROMBOPHILIA; TURKEY; YOUNG ADULT;

EID: 73949097566     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00770.x     Document Type: Article

References (67)

1. Vettriselvi V, Vijayalakshmi K, Paul SF, Venkatachalam P. ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss. J Obstet Gynaecol Res 2008, 34:301-306.
2. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, Batun S, Isi H. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol 2007, 10:727-731.
3. Regan L, Rai R. Thrombophilia and pregnancy loss. J Reprod Immunol 2002, 55:163-180.
4. Sarig G, Younis JS, Hoffman R, Lanir R, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002, 77:342-347.
5. Wramsby ML, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of Factor V Leiden mutation. Fertil Steril 2000, 74:987-991.
6. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir L. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999, 82:6-9.
7. Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF. Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod 1999, 14:2448-2450.
8. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 2006, 56:230-236.
9. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, Makris PE, Bontis J, Kotsis A. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000, 5:458-462.
10. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilia and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004, 164:558-563.
11. Pihusch R, Buchholz T, Lohse P, Rubsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001, 46:124-131.
12. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003, 361:901-908.
13. Rai R, Shlebak A, Cohen A, Backos M. Factor V Leiden and acquired activated protein C resistance among women with recurrent miscarriage. Hum Reprod 2001, 16:961-965.
14. Pauer HU, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G. Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstet Gynecol Scand 2003, 82:942-947.
15. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999, 71:1048-1053.
16. Pickering W, Marriott K, Regan L. G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Hemost 2001, 7:25-28.
17. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002, 17:1633-1637.
18. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006, 55:360-368.
19. Wolf CE, Haubelt H, Pauer HU, Hinney B, Krome-Cesar C, Legler TJ, Hellstern P, Emons G, Zoll B, Köhler M. Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb 2003, 33:134-137.
20. Wang XP, Lin QD, Ma ZW, Zhao AM. C677T and A1298C mutation of the methylenetetrahydrofolate reductase gene in unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi 2004, 39:238-241.
21. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsman PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67.
22. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1968, 8:3698-3703.
23. Kluijtmans LA, van den Heuvel LP, Boers GH, Frost P, Stevens EM, van Oost BA, Den Hijer M, Trijbels FJ, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996, 5:35-41.
24. Coumans AB, Huijgens PC, Jakobs C, Schats R, de Vries JI, Van Pampus MG, Dekker GA. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod 1999, 14:211-214.
25. Muszbek L. Deficiency causing mutations and common polymorphisms in the factor XIII-A gene. Thromb Haemost 2000, 84:524-527.
26. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000, 96:988-995.
27. Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG, Teisner B. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 2000, 21:754-762.
28. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa and are distinguishable by DNA typing. J Clin Invest 1989, 83:1778-1781.
29. McGladdery SH, Frohlich JJ. Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy. J Lipid Res 2001, 42:1905-1912.
30. Goodman C, Goodman CS, Hur J, Jeyendran RS, Coulam C. The association of Apoprotein E polymorphisms with recurrent pregnancy loss. Am J Reprod Immunol 2009, 61:34-38.
31. Buchholz T, Thaler CJ. Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol 2003, 49:1-13.
32. Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, Girolami A, Bernardi F. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood 2000, 96:1443-1448.
33. Ozcan T, Rinder HM, Murphy J, Kohn C, Copel JA. Genetic thrombophilia and thromboembolic complications. Am J Obstet Gynecol 2001, 184:189.
34. Behjati R, Modarressi MH, Jeddi-Tehrani M, Dokoohaki P, Ghasemi J, Zarnani AH, Aarabi M, Memariani T, Ghaffari M, Akhondi MA. Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion. Ann Hematol 2006, 85:268-271.
35. Hopmeier P, Puehringer H, van Trotsenburg M, Atamaniuk J, Oberkanins C, Dossenbach-Glaninger A. Association of endothelial protein C receptor haplotypes, factor V Leiden and recurrent first trimester pregnancy loss. Clin Biochem 2008, 41:1022-1024.
36. Jivraj S, Rai R, Underwood J, Regan L. Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod 2006, 21:1161-1165.
37. Pasrinen T, Perola M, Niini P, Terwilliger J, Salomaa V, Varriainen E, Peltone L, Syvanen AC. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet 1998, 7:1453-1462.
38. Kohler HP, Futers TS, Grant PJ. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Association with FXIII activity and antigen levels. Thromb Haemost 1999, 81:511-515.
39. Kakko S, Elo T, Tapanainen JM, Huikuri HV, Savolainen MJ. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 2002, 32:643-648.
40. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J, Hopmeier P. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 2003, 49:1081-1086.
41. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou JP, Scarabin PY, Bara L, Green F, Cambien F. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996, 93:440-449.
42. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T. The 4G/5G of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000, 49:845-852.
43. Eriksson P, Kallin B, van Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995, 92:1851-1855.
44. Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 1998, 80:956-960.
45. Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG. Platelet glycoprotein IIb/IIIa homozygosity associated with risk of ischemic cardiovascular diseases and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 2003, 42:661-667.
46. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000, 74:1196-1199.
47. Zetterberg H, Regland B, Palmér M, Ricksten A, Palmqvist L, Rymo L, Arvanitis DA, Spandidos DA, Blennow K. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002, 10:113-118.
48. Fatini C, Gensini F, Sticchi E, Battaglini B, Prisco D, Fedi S, Brunelli T, Marcucci R, Conti AA, Gensini GF, Abbate R. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003, 33:642-647.
49. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, Marcucci R, Brunelli T, Mello G, Parretti E, Pepe G, Abbate R. Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis 2000, 11:657-662.
50. Hohlagschwandtner M, Unfried G, Heinze G, Huber JC, Nagele F, Tempfer C. Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. Fertil Steril 2003, 79:1141-1148.
51. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Prevalence of Factor V G1691A (Factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002, 71:300-305.
52. Reznikoff-Etiévant MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J. Factor V Leiden and prothrombin mutations are risk factors for very early recurrent miscarriage. Br J Obstet Gynaecol 2001, 108:1251-1254.
53. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004, 91:700-711.
54. Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M. Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000, 43:31-35.
55. Dizon-Townson DS, Kinney S, Branch DW, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997, 34:217-223.
56. Hashimoto K, Shizusawa Y, Shimoya K, Ohashi K, Shimizu T, Azuma C, Murata Y. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod 1999, 14:1872-1874.
57. Blumenfeld Z, Brenner B. Thrombophilia associated pregnancy wastage. Fertil Steril 1999, 72:765-774.
58. Mtiraoui N, Zammiti W, Ghazouani L, Braham NJ, Saidi S, Finan RR, Almawi WY, Mahjoub T. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction 2006, 131:395-401.
59. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 1997, 17:2082-2087.
60. Vaughan DE. Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease. Eur Heart J 1998, 19:9-12.
61. Heby O. DNA methylation and polyamines in embryonic development and cancer. Int J Dev Biol 1995, 39:737-757.
62. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, Genuardi M, Abbate R, Fatini C. Maternal-fetal flow, negative events, and preecalmpsia. Role of ACE I/D polymorphism. Hypertension 2003, 41:932-937.
63. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991, 65:487-490.
64. Humphries SE, Cook M, Dubovitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987, 1:1452-1455.
65. Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Mannucci PM. A factor V gene component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997, 90:1552-1557.
66. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004, 141:137-147.
67. Shechter M, Bairy Merz CN, Paul-Labrador MJ, Shah PK, Kaul S. Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease. Cardiology 1999, 92:151-155.